+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Heart Pump Devices - Global Market Trajectory & Analytics

  • ID: 4804856
  • Report
  • April 2021
  • Region: Global
  • 224 pages
  • Global Industry Analysts, Inc
Global Heart Pump Devices Market to Reach $8 Billion by 2027

Amid the COVID-19 crisis, the global market for Heart Pump Devices estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$8 Billion by 2027, growing at a CAGR of 19.2% over the analysis period 2020-2027. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is projected to record a 20.4% CAGR and reach US$3.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intra-aortic Balloon Pumps (IABPs) segment is readjusted to a revised 18.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $694.2 Million, While China is Forecast to Grow at 18.4% CAGR

The Heart Pump Devices market in the U.S. is estimated at US$694.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.3% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14% CAGR.

Total Artificial Heart (TAH) Segment to Record 18.9% CAGR

In the global Total Artificial Heart (TAH) segment, USA, Canada, Japan, China and Europe will drive the 18.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$160.6 Million in the year 2020 will reach a projected size of US$532.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$968.6 Million by the year 2027.

Select Competitors (Total 44 Featured):
  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Europe NV
Note: Product cover images may vary from those shown

  • Influencer Market Insights
  • Product Overview
  • Heart Pump Device: A Prelude
  • Impact of Covid-19 and a Looming Global Recession
  • Rising Incidence of Cardiovascular Diseases: A Strong Growth Driver
  • Innovations in Heart Pump Technology

  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown